Hantech Bio-Technology Co., Ltd.(TW:1294)
NT$44.80+0.25 (+0.56%)
TW:1294
Hantech Bio-Technology Co., Ltd. financials statements
NT$44.80
At close:+0.25 (+0.56%)
Hantech Bio-Technology Co., Ltd. (1294) Ratios
Hantech Bio-Technology Co., Ltd. Ratios
TW:1294's free cash flow for Q2 2026 was NT$25.70M. For the 2026 fiscal year, TW:1294's free cash flow was decreased by NT$-18.21M and operating cash flow was NT$43.91M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.40 | 2.78 | 1.52 | 1.64 | 2.01 |
| Quick Ratio | 1.95 | 2.45 | 1.17 | 1.36 | 1.73 |
| Cash Ratio | 1.01 | 1.99 | 0.74 | 0.78 | 1.28 |
| Solvency Ratio | 0.53 | 0.63 | 0.32 | 0.33 | 0.26 |
| Operating Cash Flow Ratio | 0.65 | 0.78 | 0.86 | 0.65 | 0.66 |
| Short-Term Operating Cash Flow Coverage | 5.33 | 0.00 | 8.28 | 9.11 | 11.10 |
| Net Current Asset Value | NT$ 257.44M | NT$ 236.45M | NT$ -189.65M | NT$ -46.34M | NT$ -62.56M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.10 | 0.33 | 0.24 | 0.37 |
| Debt-to-Equity Ratio | 0.14 | 0.13 | 0.77 | 0.42 | 0.80 |
| Debt-to-Capital Ratio | 0.12 | 0.12 | 0.44 | 0.30 | 0.44 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.10 | 0.42 | 0.24 | 0.39 |
| Financial Leverage Ratio | 1.41 | 1.37 | 2.34 | 1.77 | 2.15 |
| Debt Service Coverage Ratio | 5.35 | 35.88 | 6.70 | 7.93 | 9.25 |
| Interest Coverage Ratio | 58.11 | 36.73 | 87.76 | 40.68 | 25.12 |
| Debt to Market Cap | 0.05 | 0.05 | 0.17 | 0.12 | 0.17 |
| Interest Debt Per Share | 3.84 | 3.97 | 11.14 | 3.58 | 4.42 |
| Net Debt to EBITDA | -0.64 | -1.18 | 0.68 | 0.48 | 0.91 |
| Profitability Margins | |||||
| Gross Profit Margin | 36.45% | 40.85% | 44.93% | 41.86% | 42.04% |
| EBIT Margin | 22.22% | 26.73% | 29.71% | 19.57% | 16.63% |
| EBITDA Margin | 27.12% | 31.01% | 33.06% | 25.96% | 24.42% |
| Operating Profit Margin | 22.22% | 26.38% | 29.71% | 19.77% | 16.19% |
| Pretax Profit Margin | 22.22% | 26.01% | 29.52% | 19.08% | 15.99% |
| Net Profit Margin | 17.86% | 20.80% | 23.69% | 15.69% | 13.55% |
| Continuous Operations Profit Margin | 17.86% | 20.77% | 23.60% | 15.16% | 12.94% |
| Net Income Per EBT | 80.39% | 79.98% | 80.25% | 82.24% | 84.75% |
| EBT Per EBIT | 100.02% | 98.58% | 99.39% | 96.53% | 98.73% |
| Return on Assets (ROA) | 11.92% | 13.91% | 15.91% | 10.02% | 8.67% |
| Return on Equity (ROE) | 16.77% | 19.04% | 37.21% | 17.79% | 18.65% |
| Return on Capital Employed (ROCE) | 18.81% | 21.30% | 26.28% | 15.87% | 12.62% |
| Return on Invested Capital (ROIC) | 14.55% | 16.90% | 20.16% | 12.17% | 9.87% |
| Return on Tangible Assets | 11.97% | 13.99% | 15.97% | 10.06% | 8.69% |
| Earnings Yield | 7.00% | 7.75% | 8.18% | 6.02% | 4.78% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.75 | 9.27 | 7.07 | 6.04 | 9.63 |
| Payables Turnover | 4.28 | 9.56 | 3.47 | 5.22 | 10.18 |
| Inventory Turnover | 4.41 | 7.00 | 4.46 | 6.59 | 7.51 |
| Fixed Asset Turnover | 1.38 | 1.32 | 1.13 | 1.06 | 1.06 |
| Asset Turnover | 0.67 | 0.67 | 0.67 | 0.64 | 0.64 |
| Working Capital Turnover Ratio | 2.26 | 3.27 | 7.04 | 4.66 | 3.70 |
| Cash Conversion Cycle | 60.86 | 53.36 | 28.38 | 45.82 | 50.66 |
| Days of Sales Outstanding | 63.53 | 39.39 | 51.63 | 60.40 | 37.90 |
| Days of Inventory Outstanding | 82.67 | 52.17 | 81.89 | 55.35 | 48.60 |
| Days of Payables Outstanding | 85.35 | 38.20 | 105.14 | 69.94 | 35.84 |
| Operating Cycle | 146.21 | 91.56 | 133.52 | 115.75 | 86.50 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.31 | 5.30 | 6.91 | 1.98 | 1.39 |
| Free Cash Flow Per Share | 4.80 | 4.40 | -3.79 | -0.64 | -1.13 |
| Dividend Paid and CapEx Coverage Ratio | 1.56 | 3.36 | 0.61 | 0.76 | 0.50 |
| Capital Expenditure Coverage Ratio | 10.40 | 5.94 | 0.65 | 0.76 | 0.55 |
| Operating Cash Flow Coverage Ratio | 1.42 | 1.40 | 0.62 | 0.56 | 0.32 |
| Operating Cash Flow to Sales Ratio | 0.21 | 0.20 | 0.31 | 0.21 | 0.18 |
| Free Cash Flow Yield | 7.31% | 6.24% | -5.82% | -2.59% | -5.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 14.28 | 11.72 | 12.22 | 16.62 | 20.91 |
| Price-to-Sales (P/S) Ratio | 2.55 | 2.68 | 2.90 | 2.61 | 2.83 |
| Price-to-Book (P/B) Ratio | 2.39 | 2.46 | 4.55 | 2.96 | 3.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.68 | 16.02 | -17.19 | -38.60 | -18.95 |
| Price-to-Operating Cash Flow Ratio | 12.36 | 13.32 | 9.44 | 12.49 | 15.34 |
| Price-to-Earnings Growth (PEG) Ratio | -0.61 | 0.91 | 0.05 | 0.36 | -0.28 |
| Enterprise Value Multiple | 8.76 | 7.47 | 9.44 | 10.53 | 12.51 |
| Enterprise Value | 1.85B | 1.73B | 1.95B | 826.77M | 733.95M |
| EV to EBITDA | 8.76 | 7.47 | 9.44 | 10.53 | 12.51 |
| EV to Sales | 2.38 | 2.32 | 3.12 | 2.73 | 3.05 |
| EV to Free Cash Flow | 12.74 | 13.83 | -18.52 | -40.45 | -20.43 |
| EV to Operating Cash Flow | 11.51 | 11.50 | 10.16 | 13.09 | 16.54 |
| Tangible Book Value Per Share | 27.39 | 28.63 | 14.34 | 8.37 | 5.53 |
| Shareholders’ Equity Per Share | 27.42 | 28.73 | 14.34 | 8.36 | 5.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.20 | 0.20 | 0.21 | 0.19 |
| Revenue Per Share | 25.75 | 26.30 | 22.52 | 9.48 | 7.53 |
| Net Income Per Share | 4.60 | 5.47 | 5.34 | 1.49 | 1.02 |
| Tax Burden | 0.80 | 0.80 | 0.80 | 0.82 | 0.85 |
| Interest Burden | 1.00 | 0.97 | 0.99 | 0.98 | 0.96 |
| Research & Development to Revenue | 0.02 | 0.01 | 0.01 | 0.03 | 0.03 |
| SG&A to Revenue | 0.13 | 0.13 | 0.14 | 0.20 | 0.23 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Income Quality | 1.16 | 0.77 | 1.04 | 1.09 | 1.16 |
Currency in TWD
